{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:26:01Z","timestamp":1789539961007,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PRINCEPS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The spread of carbapenemase-producing <jats:italic>Enterobacteriaceae<\/jats:italic> (CPE) in healthcare settings is a major public health threat that has been associated with cross-border and local patient transfers between healthcare facilities. Since the impact of transfers on spread may vary, our study aimed to assess the contribution of a patient transfer network on CPE incidence and spread at a countrywide level, with a case study of France from 2012 to 2015. Our results suggest a transition in 2013 from a CPE epidemic sustained by internationally imported episodes to an epidemic sustained by local transmission events through patient transfers. Incident episodes tend to occur within close spatial distance of their potential infector. We also observe an increasing frequency of multiple spreading events, originating from a limited number of regional hubs. Consequently, coordinated prevention and infection control strategies should focus on transfers of carriers of CPE to reduce regional and inter-regional transmission.<\/jats:p>","DOI":"10.1038\/s41598-020-71212-6","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T10:03:14Z","timestamp":1599732194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015"],"prefix":"10.1038","volume":"10","author":[{"given":"Narimane","family":"Nekkab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cr\u00e9pey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Astagneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulla","family":"Opatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Temime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"71212_CR1","doi-asserted-by":"publisher","unstructured":"Falagas, M. E., Lourida, P., Poulikakos, P., Rafailidis, P., I. & Tansarli, G. S. Antibiotic treatment of infections due to carbapenem-resistant enterobacteriaceae: systematic evaluation of the available evidence. https:\/\/doi.org\/10.1128\/AAC.01222-13 (2014).","DOI":"10.1128\/AAC.01222-13"},{"key":"71212_CR2","doi-asserted-by":"publisher","first-page":"ofv050","DOI":"10.1093\/ofid\/ofv050","volume":"2","author":"HJ Morrill","year":"2015","unstructured":"Morrill, H. J., Pogue, J. M., Kaye, K. S. & LaPlante, K. L. Treatment options for carbapenem-resistant enterobacteriaceae infections. Open Forum Infect. Dis. 2, ofv050. https:\/\/doi.org\/10.1093\/ofid\/ofv050 (2015).","journal-title":"Open Forum Infect. Dis."},{"key":"71212_CR3","doi-asserted-by":"publisher","first-page":"1900123","DOI":"10.2807\/1560-7917.ES.2019.24.9.1900123","volume":"24","author":"A Brolund","year":"2019","unstructured":"Brolund, A. et al. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018. Eurosurveillance 24, 1900123. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.9.1900123 (2019).","journal-title":"Eurosurveillance"},{"key":"71212_CR4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062","author":"B Albiger","year":"2015","unstructured":"Albiger, B. et al. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2015.20.45.30062 (2015).","journal-title":"Euro Surveill."},{"key":"71212_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/jac\/dki389","volume":"57","author":"N Kassis-Chikhani","year":"2006","unstructured":"Kassis-Chikhani, N. et al. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying bla(VIM-1) and bla(SHV-5) in a French university hospital. J. Antimicrob. Chemother. 57, 142\u2013145. https:\/\/doi.org\/10.1093\/jac\/dki389 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"71212_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jac\/dkq132","volume":"65","author":"N Kassis-Chikhani","year":"2010","unstructured":"Kassis-Chikhani, N. et al. Outbreak of Klebsiella pneumoniae producing KPC-2 and SHV-12 in a French hospital. J. Antimicrob. Chemother. 65, 1539\u20131540. https:\/\/doi.org\/10.1093\/jac\/dkq132 (2010).","journal-title":"J. Antimicrob. Chemother."},{"key":"71212_CR7","unstructured":"ECDC. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer (Stockholm, 2011)."},{"key":"71212_CR8","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","volume":"69","author":"Y Doi","year":"2019","unstructured":"Doi, Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin. Infect. Dis. 69, S565\u2013S575. https:\/\/doi.org\/10.1093\/cid\/ciz830 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"71212_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1017\/ice.2015.130","volume":"36","author":"JE Simmering","year":"2015","unstructured":"Simmering, J. E., Polgreen, L. A., Campbell, D. R., Cavanaugh, J. E. & Polgreen, P. M. Hospital transfer network structure as a risk factor for clostridium difficile infection. Infect. Control Hosp. Epidemiol. 36, 1031\u20131037. https:\/\/doi.org\/10.1017\/ice.2015.130 (2015).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"71212_CR10","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1038\/s41598-017-02245-7","volume":"7","author":"J Fern\u00e1ndez-Gracia","year":"2017","unstructured":"Fern\u00e1ndez-Gracia, J., Onnela, J.-P., Barnett, M. L., Egu\u00edluz, V. M. & Christakis, N. A. Influence of a patient transfer network of US inpatient facilities on the incidence of nosocomial infections. Sci. Rep. 7, 2930. https:\/\/doi.org\/10.1038\/s41598-017-02245-7 (2017).","journal-title":"Sci. Rep."},{"key":"71212_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/cid\/ciw461","volume":"63","author":"MJ Ray","year":"2016","unstructured":"Ray, M. J., Lin, M. Y., Weinstein, R. A. & Trick, W. E. Spread of carbapenem-resistant enterobacteriaceae among Illinois healthcare facilities: the role of patient sharing. Clin. Infect. Dis. 63, 889\u2013893. https:\/\/doi.org\/10.1093\/cid\/ciw461 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"71212_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/aje\/kwv299","volume":"183","author":"BY Lee","year":"2016","unstructured":"Lee, B. Y. et al. The potential trajectory of carbapenem-resistant Enterobacteriaceae, an emerging threat to health-care facilities, and the impact of the centers for disease control and prevention toolkit. Am. J. Epidemiol. 183, 471\u2013479. https:\/\/doi.org\/10.1093\/aje\/kwv299 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"71212_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijmm.2013.02.003","volume":"303","author":"M Ciccolini","year":"2013","unstructured":"Ciccolini, M. et al. Infection prevention in a connected world: the case for a regional approach. Int. J. Med. Microbiol. 303, 380\u2013387. https:\/\/doi.org\/10.1016\/j.ijmm.2013.02.003 (2013).","journal-title":"Int. J. Med. Microbiol."},{"key":"71212_CR14","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1128\/aac.01761-10","volume":"55","author":"L Poirel","year":"2011","unstructured":"Poirel, L., Fortineau, N. & Nordmann, P. International transfer of NDM-1-producing Klebsiella pneumoniae from Iraq to France. Antimicrob. Agents Chemother. 55, 1821\u20131822. https:\/\/doi.org\/10.1128\/aac.01761-10 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"71212_CR15","doi-asserted-by":"publisher","DOI":"10.2807\/ese.16.22.19880-en","author":"S Vaux","year":"2011","unstructured":"Vaux, S. et al. Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011. Euro Surv. https:\/\/doi.org\/10.2807\/ese.16.22.19880-en (2011).","journal-title":"Euro Surv."},{"key":"71212_CR16","unstructured":"ECDC. Rapid risk assessment: carbapenem-resistant Enterobacteriaceae (Stockholm, 2016)."},{"key":"71212_CR17","doi-asserted-by":"publisher","first-page":"e1005666","DOI":"10.1371\/journal.pcbi.1005666","volume":"13","author":"N Nekkab","year":"2017","unstructured":"Nekkab, N., Astagneau, P., Temime, L. & Crepey, P. Spread of hospital-acquired infections: a comparison of healthcare networks. PLoS Comput. Biol. 13, e1005666. https:\/\/doi.org\/10.1371\/journal.pcbi.1005666 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"71212_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ofid\/ofv050","volume":"2","author":"HJ Morrill","year":"2015","unstructured":"Morrill, H. J., Pogue, J. M., Kaye, K. S., & LaPlante, K. L. Treatment options for carbapenem-resistant Enterobacteriaceae infections.\u00a0Open Forum Infect. Dis.\u00a02, 2. https:\/\/doi.org\/10.1093\/ofid\/ofv050 (2015).","journal-title":"Open Forum Infect. Dis."},{"key":"71212_CR19","doi-asserted-by":"publisher","first-page":"e1004170","DOI":"10.1371\/journal.pcbi.1004170","volume":"11","author":"T Obadia","year":"2015","unstructured":"Obadia, T. et al. Detailed contact data and the dissemination of Staphylococcus aureus in hospitals. PLoS Comput. Biol. 11, e1004170. https:\/\/doi.org\/10.1371\/journal.pcbi.1004170 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"71212_CR20","doi-asserted-by":"publisher","unstructured":"Fournier, S. et al. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012. https:\/\/doi.org\/10.2807\/1560-7917.ES2014.19.19.20802 (2014).","DOI":"10.2807\/1560-7917.ES2014.19.19.20802"},{"key":"71212_CR21","doi-asserted-by":"publisher","DOI":"10.2807\/ese.15.48.19734-en","author":"A Carbonne","year":"2010","unstructured":"Carbonne, A. et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill. https:\/\/doi.org\/10.2807\/ese.15.48.19734-en (2010).","journal-title":"Euro Surveill."},{"key":"71212_CR22","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.ajic.2015.05.021","volume":"43","author":"T Delory","year":"2015","unstructured":"Delory, T. et al. Prolonged delay for controlling KPC-2-producing Klebsiella pneumoniae outbreak: the role of clinical management. Am. J. Infect. Control 43, 1070\u20131075. https:\/\/doi.org\/10.1016\/j.ajic.2015.05.021 (2015).","journal-title":"Am. J. Infect. Control"},{"key":"71212_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12916-017-0844-2","volume":"15","author":"T Donker","year":"2017","unstructured":"Donker, T. et al. The relative importance of large problems far away versus small problems closer to home: insights into limiting the spread of antimicrobial resistance in England. BMC Med. 15, 86. https:\/\/doi.org\/10.1186\/s12916-017-0844-2 (2017).","journal-title":"BMC Med."},{"key":"71212_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jhin.2015.04.002","volume":"90","author":"D Lepelletier","year":"2015","unstructured":"Lepelletier, D. et al. French recommendations for the prevention of \u201cemerging extensively drug-resistant bacteria\u201d (eXDR) cross-transmission. J. Hosp. Infect. 90, 186\u2013195. https:\/\/doi.org\/10.1016\/j.jhin.2015.04.002 (2015).","journal-title":"J. Hosp. Infect."},{"key":"71212_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1371\/journal.pcbi.1004170","volume":"11","author":"T Obadia","year":"2015","unstructured":"Obadia, T. et al. Detailed contact data and the dissemination of Staphylococcus aureus in hospitals. PLoS Comput. Biol. 11, 16. https:\/\/doi.org\/10.1371\/journal.pcbi.1004170 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"71212_CR26","first-page":"1","volume":"1695","author":"G Csardi","year":"2006","unstructured":"Csardi, G. & Nepusz, T. The igraph software package for complex network research. InterJ. Complex Syst. 1695, 1\u20139 (2006).","journal-title":"InterJ. Complex Syst."},{"key":"71212_CR27","unstructured":"Nekkab, N. Spread of hospital-acquired infections and emerging multidrug resistant enterobacteriaceae in healthcare networks : assessment of the role of interfacility patient transfers on infection risks and control measures. Conservatoire national des arts et metiers - CNAM (2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71212-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71212-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71212-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:32:00Z","timestamp":1670351520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-71212-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["71212"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-71212-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LO received research funding from Pfizer (through their research unit) on a project related to meningococcal epidemiology. LO received consulting fees from WHO for work on antimicrobial resistance. The rest of the authors have no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14910"}}